0001213900-22-080971.txt : 20221219 0001213900-22-080971.hdr.sgml : 20221219 20221219170434 ACCESSION NUMBER: 0001213900-22-080971 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221216 FILED AS OF DATE: 20221219 DATE AS OF CHANGE: 20221219 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tegge Jonathan CENTRAL INDEX KEY: 0001755310 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39685 FILM NUMBER: 221471911 MAIL ADDRESS: STREET 1: 217 W. MAIN STREET CITY: SOMERVILLE STATE: NJ ZIP: 08876 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: InMed Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001728328 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: SUITE 310, 815 W. HASTINGS STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 1B4 BUSINESS PHONE: (604) 669-7207 MAIL ADDRESS: STREET 1: SUITE 310, 815 W. HASTINGS STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 1B4 4 1 ownership.xml X0306 4 2022-12-16 0 0001728328 InMed Pharmaceuticals Inc. INM 0001755310 Tegge Jonathan C/O INMED PHARMACEUTICALS INC. 310-815 WEST HASTINGS ST. VANCOUVER A1 V6C1B4 BRITISH COLUMBIA, CANADA 0 1 0 0 Interim CFO Employee Stock Option (Right to Buy) 1.78 2022-12-16 4 A 0 1400 0.00 A 2027-12-15 Common shares 1400 1400 D Vesting 1/12 per month, in arrears, for 12 months. /s/ Eric A Adams, attorney-in-fact for Mr. Jonathan Tegge 2022-12-19